309 related articles for article (PubMed ID: 29226333)
1. p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment.
Agrawal R; Garg A; Benny Malgulwar P; Sharma V; Sarkar C; Kulshreshtha R
Int J Cancer; 2018 May; 142(9):1817-1828. PubMed ID: 29226333
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
3. The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines.
Macharia LW; Muriithi W; Heming CP; Nyaga DK; Aran V; Mureithi MW; Ferrer VP; Pane A; Filho PN; Moura-Neto V
BMC Cancer; 2021 Nov; 21(1):1248. PubMed ID: 34798868
[TBL] [Abstract][Full Text] [Related]
4. The HIF1α/HIF2α-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions.
Wang P; Yan Q; Liao B; Zhao L; Xiong S; Wang J; Zou D; Pan J; Wu L; Deng Y; Wu N; Gong S
Cell Death Dis; 2020 Nov; 11(11):992. PubMed ID: 33208727
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
[TBL] [Abstract][Full Text] [Related]
6. Methylation regulates HEY1 expression in glioblastoma.
Tsung AJ; Guda MR; Asuthkar S; Labak CM; Purvis IJ; Lu Y; Jain N; Bach SE; Prasad DVR; Velpula KK
Oncotarget; 2017 Jul; 8(27):44398-44409. PubMed ID: 28574840
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA 3928 Suppresses Glioblastoma through Downregulation of Several Oncogenes and Upregulation of p53.
Mulcahy EQX; Zhang Y; Colόn RR; Cain SR; Gibert MK; Dube CJ; Hafner M; Abounader R
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409289
[TBL] [Abstract][Full Text] [Related]
8. Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment.
Jana A; Narula P; Chugh A; Kulshreshtha R
Int J Pharm; 2019 Dec; 572():118789. PubMed ID: 31726199
[TBL] [Abstract][Full Text] [Related]
9. MiR-219-5p promotes spinal cord injury recovery by inhibiting NEUROD2-regulated inflammation and oxidative stress.
Zhu Y; Xu Q; Sha WP; Zhao KP; Wang LM
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):37-43. PubMed ID: 30657544
[TBL] [Abstract][Full Text] [Related]
10. PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.
Nawaz Z; Patil V; Paul Y; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
Mol Cancer; 2016 Nov; 15(1):74. PubMed ID: 27871300
[TBL] [Abstract][Full Text] [Related]
11. MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.
Besse A; Sana J; Lakomy R; Kren L; Fadrus P; Smrcka M; Hermanova M; Jancalek R; Reguli S; Lipina R; Svoboda M; Slampa P; Slaby O
Tumour Biol; 2016 Jun; 37(6):7719-27. PubMed ID: 26692101
[TBL] [Abstract][Full Text] [Related]
12. MiR-615 inhibits cell proliferation, migration and invasion by targeting EGFR in human glioblastoma.
Ji Y; Sun Q; Zhang J; Hu H
Biochem Biophys Res Commun; 2018 May; 499(3):719-726. PubMed ID: 29605294
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis.
Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA
Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme.
Qiu S; Huang D; Yin D; Li F; Li X; Kung HF; Peng Y
Biochim Biophys Acta; 2013 Oct; 1832(10):1697-707. PubMed ID: 23707559
[TBL] [Abstract][Full Text] [Related]
15. miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3.
Li W; Huang H; Su J; Ji X; Zhang X; Zhang Z; Wang H
Mol Neurobiol; 2017 May; 54(4):2555-2561. PubMed ID: 26993295
[TBL] [Abstract][Full Text] [Related]
16. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
Wang L; Liu J; Zhong Z; Gong X; Liu W; Shi L; Li X
Brain Res; 2016 Sep; 1646():441-450. PubMed ID: 27328425
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells.
Zhang S; Lai N; Liao K; Sun J; Lin Y
Folia Neuropathol; 2015; 53(3):236-44. PubMed ID: 26443314
[TBL] [Abstract][Full Text] [Related]
18. HIF1α and p53 Regulated MED30, a Mediator Complex Subunit, is Involved in Regulation of Glioblastoma Pathogenesis and Temozolomide Resistance.
Shukla A; Srivastava S; Darokar J; Kulshreshtha R
Cell Mol Neurobiol; 2021 Oct; 41(7):1521-1535. PubMed ID: 32705436
[TBL] [Abstract][Full Text] [Related]
19. Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.
Liu X; Gao Q; Zhao N; Zhang X; Cui W; Sun J; Fu J; Hao J
Mol Carcinog; 2018 Apr; 57(4):494-502. PubMed ID: 29240260
[TBL] [Abstract][Full Text] [Related]
20. miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma.
Mathew LK; Skuli N; Mucaj V; Lee SS; Zinn PO; Sathyan P; Imtiyaz HZ; Zhang Z; Davuluri RV; Rao S; Venneti S; Lal P; Lathia JD; Rich JN; Keith B; Minn AJ; Simon MC
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):291-6. PubMed ID: 24368849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]